InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 5,500+ research and publications.
Research title with ★ indicates InBody recommended paper.

Asprosin is associated with anorexia and body fat mass in cancer patients

Cancer/ Palliative treatment
Du et al.
Used Parameters : BFM, PBF, SMM, FFM, LBM, BMR

Publication Year : 2020

Country : China

Journal : Supportive Care in Cancer

Purpose Increasing evidence suggests that many adipokines are involved in cancer-related anorexia and cachexia syndrome (CACS), although the underlying mechanism remains to be clarify. Asprosin is a new peptide hormone mainly secreted by white adipose tissues that can increase appetite and body weight. In this cross-sectional study, we tested whether asprosin may intervene in the development of CACS. Methods The fasting plasma asprosin levels were determined via enzyme-linked immune-sorbent assay. Anorexia was …
Full text